Skip to main content

Advertisement

Log in

The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine

  • Review Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

The enzymes in the cytochrome p450 monooxygenase system (CYP) are the major enzymes responsible for metabolizing medications. The CYP2D6 isomer is responsible for metabolizing certain opioids, neuroleptics, antidepressants and cardiac medications. Owing to CYP2D6's low capacity and high affinity it is easily saturated by substrate and/or inhibited, resulting in pharmacokinetic interactions. Polymorphisms of the structural gene are common, leading to wide inter-individual and ethnic differences in drug metabolism. Clinically important drug interactions, which may be anticipated in the palliative medicine population, are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Electronic Publication

Rights and permissions

Reprints and permissions

About this article

Cite this article

Davis, M.P., Homsi, J. The importance of cytochrome P450 monooxygenase CYP2D6 in palliative medicine. Support Care Cancer 9, 442–451 (2001). https://doi.org/10.1007/s005200000222

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s005200000222

Navigation